Cargando…

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children

BACKGROUND AND OBJECTIVES: This was a multicenter study to evaluate the usefulness of the tumor necrosis factor-alpha (TNF-α) blocker infliximab for treatment of Korean pediatric patients with refractory Kawasaki disease (KD). SUBJECTS AND METHODS: Data from 16 patients throughout Korea who were dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Min Seob, Lee, Sang Bum, Sohn, Sejung, Oh, Jin Hee, Yoon, Kyung Lim, Han, Ji Whan, Kim, Chul Ho
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910290/ https://www.ncbi.nlm.nih.gov/pubmed/20664742 http://dx.doi.org/10.4070/kcj.2010.40.7.334

Ejemplares similares

Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea
por: Hur, Gyu, et al.
Publicado: (2018)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Polymorphisms of Human Leukocyte Antigen Genes in Korean Children with Kawasaki Disease
por: Oh, Jin Hee, et al.
Publicado: (2007)

Infliximab as a rescue therapy in the management of refractory typical infantile Kawasaki disease
por: Venkatnarayanan, K., et al.
Publicado: (2020)

Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease
por: Shim, Yoon Hee, et al.
Publicado: (2006)

Infliximab as an alternative therapy for refractory adult onset Kawasaki disease: A case report
por: Kawaguchi, Takeshi, et al.
Publicado: (2018)

Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Kim, Hyun Kwon, et al.
Publicado: (2011)

Deep Neck Inflammation: Probable Kawasaki Disease in Korean Children
por: Lim, Sooyeon, et al.
Publicado: (2020)

The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis
por: Li, Dan, et al.
Publicado: (2021)

Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Secretion in Kawasaki Disease
por: Lim, Goh-Woon, et al.
Publicado: (2010)

Polymorphisms of methylenetetrahydrofolate reductase are not a risk factor for Kawasaki disease in the Korean population
por: Yoon, Kyung Lim, et al.
Publicado: (2011)

Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium
por: Lee, Jong-Keuk, et al.
Publicado: (2015)

Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?
por: Lee, Goni, et al.
Publicado: (2013)

Predicting Factors for Refractory Kawasaki Disease
por: Do, Young-Sun, et al.
Publicado: (2010)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide
por: Choi, Jung Eun, et al.
Publicado: (2018)

Assessment of the Clinical Heterogeneity of Kawasaki Disease Using Genetic Variants of BLK and FCGR2A
por: Sim, Bo Kyung, et al.
Publicado: (2018)

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study
por: Kim, Eun Hye, et al.
Publicado: (2015)

C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease
por: Choi, Jung Eun, et al.
Publicado: (2018)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA
por: Min, Ji-Yeon, et al.
Publicado: (2012)

Mycoplasma pneumoniae infection in patients with Kawasaki disease
por: Lee, Mi Na, et al.
Publicado: (2011)

Correlation between elevated platelet count and immunoglobulin levels in the early convalescent stage of Kawasaki disease
por: Han, Ji-Whan, et al.
Publicado: (2017)

Dramatic response to infliximab in refractory neurosarcoidosis
por: Chintamaneni, Sreekanth, et al.
Publicado: (2010)

Infliximab Treatment of Refractory Cardiac Sarcoidosis
por: Asawaeer, Majid, et al.
Publicado: (2020)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

Identification of LEF1 as a Susceptibility Locus for Kawasaki Disease in Patients Younger than 6 Months of Age
por: Kim, Hea-Ji, et al.
Publicado: (2018)

Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease
por: Choi, Han Seul, et al.
Publicado: (2015)

Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease
por: Kwon, Young-Chang, et al.
Publicado: (2017)

Efficacy of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis
por: Lu, Zhongxing, et al.
Publicado: (2021)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora
por: Lee, Kyung-Yil, et al.
Publicado: (2007)

Usefulness of anterior uveitis as an additional tool for diagnosing incomplete Kawasaki disease
por: Lee, Kyu Jin, et al.
Publicado: (2016)

Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age
por: Bae, Hyun Kyung, et al.
Publicado: (2014)

T-Helper Cytokine Profiles in Patients with Kawasaki Disease
por: Lee, Sang Bum, et al.
Publicado: (2015)

Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial
por: Mori, Masaaki, et al.
Publicado: (2018)

Verification of Current Risk Scores for Kawasaki Disease in Korean Children
por: Shin, Jaeeun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o49qlhpq04mhok7cmkfe3c4mt6